Literature DB >> 6771004

Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.

M Morimoto, D Green, A Rahman, A Goldin, P S Schein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6771004

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

Review 1.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumors.

Authors:  J Dubois; G Atassi; M Hanocq; F Abikhalil
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Clinical pharmacokinetics of altretamine.

Authors:  G Damia; M D'Incalci
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

Review 4.  Hexamethylmelamine and hexamethylmelamine hydrochloride.

Authors:  H P van de Vaart-van Zutphen; C F Smulders; J Renema; A Hulshoff
Journal:  Pharm Weekbl Sci       Date:  1982-04-23

5.  Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.

Authors:  J R Muindi; D R Newell; I E Smith; K R Harrap
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.